On the accuracy of a one-compartment approach for determination of drug terminal half-life

被引:3
|
作者
Berezhkovskiy, Leonid M. [1 ]
机构
[1] Genentech Inc, San Francisco, CA 94080 USA
关键词
terminal half-life; steady state volume of distribution; terminal volume of distribution; clearance; mean residence time; blood flow; blood-plasma ratio; hepatic clearance; physiological model; pharmacikinetics; STEADY-STATE; PHYSIOLOGICAL-PARAMETERS; PHARMACOKINETICS; VOLUME; PREDICTION; CLEARANCE; BODY;
D O I
10.1002/jps.23565
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The drug terminal half-life (t1/2) is commonly predicted by a simplified one-compartment approach (t1/2 = ln 2Vss/CL), where Vss and CL are the steady-state volume of distribution and the total body clearance of drug, respectively. The analysis of the accuracy of this approach is provided. It turns out that most often a simplified one-compartment calculation underestimates t1/2 by no more than 25% for human, 26% for dog, 20% for monkey, 19% for rat, and 23% for mouse. Thus, the application of a one-compartment calculation of t1/2 is well justifiable, except for the rare cases of very high drug clearance (@@@@), where r is the equilibrium blood-plasma concentration ratio, and Q is the cardiac output. (c) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:2082-2084, 2013
引用
收藏
页码:2082 / 2084
页数:3
相关论文
共 45 条
  • [41] Revised terminal half-life of nonacog alfa as derived from extended sampling data: A real-world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis
    Tardy, Brigitte
    Lambert, Thierry
    Chamouni, Pierre
    Montmartin, Aurelie
    Trossaert, Marc
    Claeyssens, Segolene
    Berger, Claire
    Ardillon, Laurent
    Gay, Valerie
    Delavenne, Xavier
    Harroche, Annie
    Chelle, Pierre
    HAEMOPHILIA, 2022, 28 (04) : 542 - 547
  • [42] Application of the Stable Isotope Label Approach in Clinical Development—Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound
    Navin Goyal
    Khadeeja Mohamed
    Katie Rolfe
    Satty Sahota
    Terry Ernest
    Stephan Duparc
    Maxine Taylor
    Linda Casillas
    Gavin C. K. W. Koh
    The AAPS Journal, 20
  • [43] A nonradioisotope biomedical assay for intact oligonucleotide and its chain-shortened metabolites used for determination of exposure and elimination half-life of antisense drugs in tissue
    Geary, RS
    Matson, J
    Levin, AA
    ANALYTICAL BIOCHEMISTRY, 1999, 274 (02) : 241 - 248
  • [44] Application of the Stable Isotope Label Approach in Clinical Development-Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound
    Goyal, Navin
    Mohamed, Khadeeja
    Rolfe, Katie
    Sahota, Satty
    Ernest, Terry
    Duparc, Stephan
    Taylor, Maxine
    Casillas, Linda
    Koh, Gavin C. K. W.
    AAPS JOURNAL, 2018, 20 (04):